PW:Phase II clinical trials...by the_end_of 2014.
Sep, Oct, Nov, Dec --- Phase 2 folks!
PW: Our number one corporate objective, following good discussion with the FDA, is to initiate the Phase II clinical trials of these important programs by the end of 2014.
The RS makes ACTC even cleaner. She now has
a clean balance and a low float!
PW:We have a clean balance sheet that can be turned into a strong balance sheet with proper financing to support our robust medical program.
PW: We have a clean balance sheet that can be turned into a strong balance sheet with proper financing to support our robust medical program.
